Mubadala Bio partners with Valeo Health to sell wellness products online

Mubadala Bio is making a big push into e-commerce. The UAE healthcare company has signed an agreement with digital health platform Valeo Health to sell its wellness and longevity products directly to consumers online.

The deal marks Mubadala Bio's first major step into the direct-to-consumer space. Valeo Health will serve as the exclusive online partner for Al Ittihad Drug Store (IDS), Mubadala Bio's retail pharmacy chain.

How will it work?

Under the partnership, IDS products from its longevity and wellness segments will be available through Valeo Health's digital platform. The online channel will complement IDS's existing physical pharmacy locations across the UAE.

Valeo Health operates across the Gulf region and offers:

• More than 6,000 health and wellness products
• At-home services including blood tests and IV therapies
• Weight management and longevity programs
• Expert-led healthcare consultations

Why does it matter?

The partnership reflects a broader shift in how people buy healthcare products. More consumers want the convenience of ordering supplements, wellness products, and health services online rather than visiting physical stores.

For Mubadala Bio, the deal offers a way to reach new customers without the cost of opening more physical locations. The company can test demand for direct-to-consumer sales while using Valeo's existing digital infrastructure and customer base.

The context

Mubadala Bio is part of Mubadala Investment Company, Abu Dhabi's sovereign wealth fund. The company has been expanding its healthcare footprint across the Middle East through acquisitions and partnerships.

The move into e-commerce comes as digital health platforms see rapid growth in the Gulf region. Companies like Vezeeta and Altibbi have raised millions to build online healthcare services, while traditional pharmacies face pressure to offer digital alternatives.

Khalid Alkaf, General Manager of Pharma Logistics at Mubadala Bio, signed the agreement alongside Sundeep Singh, CEO and Co-founder of Valeo Health. The signing was witnessed by Hamad Husein Al Marzooqi, Group Deputy CEO of Mubadala Bio.